Prothena reported $-50332000 in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Agios Pharmaceuticals AGIO:US USD -91090000 6.55M
Akebia Therapeutics AKBA:US USD -47994000 96.43M
ALKERMES ALKS:US USD -60641000 26.18M
Alnylam Pharmaceuticals ALNY:US USD -258040000 66.35M
Amgen AMGN:US USD 2.23B 436M
Biogen BIIB:US USD 872.1M 68.8M
Biomarin Pharmaceutical BMRN:US USD -2417000 41.57M
Bluebird Bio BLUE:US USD -86480000 14.28M
Exelixis EXEL:US USD 82.61M 1.09M
Intercept Pharmaceuticals ICPT:US USD -10144000 3.22M
Intra Cellular Therapies ITCI:US USD -55629000 32.29M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
Macrogenics MGNX:US USD -24955000 16.85M
Nektar Therapeutics NKTR:US USD -37471000 10.24M
Neurocrine Biosciences NBIX:US USD 87.8M 33.1M
Prothena PRTA:US USD -50332000 7.12M
Regeneron Pharmaceuticals REGN:US USD 1.22B 83.2M
Seattle Genetics SGEN:US USD -192805000 59.69M
Ultragenyx Pharmaceutical RARE:US USD -225066000 83.47M
Vertex Pharmaceuticals VRTX:US USD 1.13B 7.4M
Vital Therapies VTL:US USD -20116000 494K
Xoma XOMA:US USD -4372000 395K
YTE INCY:US USD 118.25M 142.04M